Your CDMO+ Partner for all your Process Development and Clinical needs
Jefferson Institute for Bioprocessing is your CDMO+ Partner for process development, product development and customized training and workforce development. We offer a fully flexible, single-use facility with BSL1 and BSL2 bioprocessing capabilities.
Our team supports your organization in preclinical process development and in offering bioprocessing expertise across the major large molecule therapeutic modalities.
'Critical Considerations for Improved Cryopreservation of Cell Therapies'
Join Brent Chamberlain, Jefferson Institute for Bioprocessing’s Associate Director of Cell and Gene Therapy, as he discusses the critical consideration when optimizing cryopreservation of cell mediated therapies.
Join us on Wednesday, Aug. 30 at 11 a.m. ET.
- Process Development
- Product and Technology Development & Evaluation
- Process Analytical Technology
- Workforce Development
CDMO with a Difference
"In contrast to the traditional drug review, where 80 percent of the review is focused on the product issues, I'd say that this general principal is almost completely inverted when it comes to cell and gene therapy. The more challenging questions relate to product manufacturing and quality."
—Scott Gottlieb, MD, Former Commissioner, U.S. Food and Drug Administration